UBS Helps Lilly Buy ImClone, Says Price Too High
Bloomberg
Tue, 10/7/08 - 07:50 am
Genentech and Biogen say Rituxan slowed leukemia progress in late stage clinical trial
Yahoo/AP
Tue, 10/7/08 - 07:49 am
Four Thoughts on the Imclone/Lilly Deal
Seeking Alpha
Tue, 10/7/08 - 07:46 am
A Biotech Bonanza for ImClone and Dendreon
Seeking Alpha
Tue, 10/7/08 - 07:45 am
Synavive data sends CombinatoRx to all-time lows
Yahoo/AP
Tue, 10/7/08 - 07:44 am
Fitch may downgrade Eli Lilly's 'AA' on ImClone buy
Marketwatch
Tue, 10/7/08 - 07:43 am
Dendreon Misses, Moves Up
Forbes
Mon, 10/6/08 - 10:58 am
September FDA news in review
Fierce Pharma
Mon, 10/6/08 - 10:57 am
Icahn Wins, But Bristol Isn't A Total Loser Either
Forbes
Mon, 10/6/08 - 10:56 am
Dr. Reddy's Falls After Report on Diabetes Drug Delay
Bloomberg
Mon, 10/6/08 - 10:27 am
Genentech and OSI say Avastin and Tarceva miss main goal in late-stage clinical trial
Yahoo/AP
Mon, 10/6/08 - 09:31 am
BioSante Pharma Reaquires Elestrin
Seeking Alpha
Mon, 10/6/08 - 09:31 am
Discovery Labs: The Next Biotech Buy?
Seeking Alpha
Mon, 10/6/08 - 09:30 am
[video]Lilly/ImClone Deal
CNBC
Mon, 10/6/08 - 09:29 am
J&J biologic Crohn's disease drug outperforms standard immune-damping pill in company study
Yahoo/AP
Mon, 10/6/08 - 09:20 am
Momenta Pharma Investors In Waiting Game on Enoxaparin
Seeking Alpha
Mon, 10/6/08 - 09:19 am
Bayer's Riociguat Lung Drug Shows Exercise Benefit in Study
Bloomberg
Mon, 10/6/08 - 09:18 am
Lilly Agrees to Buy ImClone for $6.5 Billion
Bloomberg
Mon, 10/6/08 - 09:12 am
Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years
PR NewsWire
Sun, 10/5/08 - 02:11 pm
China Biotech in Review: Deals and Earnings
Seeking Alpha
Sun, 10/5/08 - 02:10 pm

Pages